Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, May 2, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
Delphia Therapeutics Adds Cancer Expert Steve Kelsey, M.D., to Board of Directors
Life Sciences Times
-
December 9, 2025
0
Venture Capital
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio
Life Sciences Times
-
December 8, 2025
0
Healthcare
Byron Jobe Named One of Modern Healthcare’s 100 Most Influential People in Healthcare
Life Sciences Times
-
December 8, 2025
0
People on the Move
Bruker Adds Diagnostics Leader Jack Phillips to Board of Directors Effective January 2026
Life Sciences Times
-
December 8, 2025
0
Biotech
Vertex Showcases New CASGEVY Data, Including First Results in Children Ages 5–11, and Prepares Global Regulatory Filings
Life Sciences Times
-
December 8, 2025
0
People on the Move
PepGen Names Joseph Vittiglio, Esq., Chief Business and Legal Officer
Life Sciences Times
-
December 8, 2025
0
Pharma
Zai Lab Begins Global Phase 1/1b Trial of ZL-1503 for Atopic Dermatitis
Life Sciences Times
-
December 8, 2025
0
Biotech
Vyome Reports Positive Phase 2 Results for VT-1953, Plans Pivotal Study for FDA Approval
Life Sciences Times
-
December 8, 2025
0
Technology
BostonGene to Present Seven AI-Driven Breast Cancer Studies at SABCS 2025
Life Sciences Times
-
December 8, 2025
0
Life Sciences
Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.
Life Sciences Times
-
December 8, 2025
0
1
...
63
64
65
...
831
Page 64 of 831
Most Popular
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026
Load more
Recent Comments
Recent Comments